Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00527332
Other study ID # EudraCT nr 2006-002520-41
Secondary ID
Status Completed
Phase Phase 4
First received September 7, 2007
Last updated January 24, 2012
Start date March 2007
Est. completion date December 2009

Study information

Verified date January 2012
Source University Hospital, Linkoeping
Contact n/a
Is FDA regulated No
Health authority Sweden: Medical Products Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether spinal anesthesia combined with intrathecal morphine in abdominal hysterectomy on benign gynecological indications gives better outcome concerning duration of hospital stay and postoperative patient comfort than general anesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date December 2009
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Female between 18 and 60 years of age.

- Scheduled for abdominal hysterectomy - total or subtotal -on benign gynecological indication.

- At least one ovary planned to be preserved at the hysterectomy.

- Can understand and communicate in Swedish

- Accept participation after written and verbal information and after signed informed consent.

- Has supervision at home after discharge from hospital during the first couple of days and has access to a telephone.

Exclusion Criteria:

- Contra-indications against spinal or general anesthesia or the standard dosage of the study drugs

- ASA classification = Class 3

- Postmenopausal women without HRT (hormone replacement therapy).

- Suspected gynecological malignancy

- Previously undergone bilateral oophorectomy

- Substantial physically disabled so that a normal recovery with early physical mobilization can not be anticipated.

- Mentally or severly psychic disabled

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Hysterectomy (MeSH nr: E04.950.300.399)

Intervention

Drug:
Bupivacain
5 mg/mL, 4 mL intrathecally as a single dos
Morphine
0.4 mg/mL; 0.5 mL intrathecally as a single dosage
Propofol
2-5 mg/kg body weight/hours IV (intravenously) for sedation during the surgery
Propofol
Induction of anesthesia with 1-2 mg/kg body weight IV (intravenously). After intubation maintenance dosage of 6-10 mg/kg/hour IV during the surgery
Fentanyl
100-200 microgram IV (intravenously) at start of anesthesia. 50-100 microgram IV on demand during surgery.
Rocuronbromid
0.6 mg/kg body weight IV (intravenously) at induction of anesthesia. If additional muscle relaxation is needed during surgery 5-10 mg is injected IV. The drug is given only at induction of anesthesia and during surgery
Morphine
5 mg is given IV (intravenously) before end of surgery

Locations

Country Name City State
Sweden Eksjö Hospital Eksjö
Sweden Ryhov Hospital Jönköping
Sweden University Hospital Linköping
Sweden Vrinnevi Hospital Norrköping
Sweden Värnamo Hospital Värnamo

Sponsors (1)

Lead Sponsor Collaborator
Preben Kjolhede

Country where clinical trial is conducted

Sweden, 

References & Publications (6)

Ellström MA, Aström M, Möller A, Olsson JH, Hahlin M. A randomized trial comparing changes in psychological well-being and sexuality after laparoscopic and abdominal hysterectomy. Acta Obstet Gynecol Scand. 2003 Sep;82(9):871-5. — View Citation

Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. Review. — View Citation

Møller C, Kehlet H, Friland SG, Schouenborg LO, Lund C, Ottesen B. Fast track hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):18-22. — View Citation

Persson P, Wijma K, Hammar M, Kjølhede P. Psychological wellbeing after laparoscopic and abdominal hysterectomy--a randomised controlled multicentre study. BJOG. 2006 Sep;113(9):1023-30. — View Citation

Vårdtid, funktionskapacitet och sjukskrivningstider efter hysterektomi. Nationella data från 6503 patienter opererade år 2000 och 2001. Återrapport från Nationella registret för kvalitetsutveckling inom gynekologisk kirurgi (Gynop-registret), SFOG, 2003.

Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of Hospital Stay. Duration of hospital stay defined as time from start anesthesia to leaving the hospital Within 6 months after surgery Yes
Secondary Occurrence and Degree of Postoperative Symptoms. Within 6 months after the surgery Yes
Secondary Postoperative Consumption of Analgesics and Antiemetics. Within 6 months after surgery No
Secondary Complications and Complication Rates. Within 6 months after the surgery Yes
Secondary Quality of Life and QALYs (Quality Adjusted Life Years). Within 6 months after the surgery No
Secondary Sick Leave. Within 6 months after the surgery No
Secondary The Stress Coping Ability Impact on Postoperative Symptoms and Recovery. Within 6 months after the surgery No
Secondary Health-related Economy. Within 6 months after the surgery No